Three weeks of treatment tied to reduction in symptoms and esophageal acid exposure time
TUESDAY, Feb. 4, 2025 (HealthDay News) — A transcutaneous electrical stimulation system (TESS) is effective in reducing both symptoms and esophageal acid exposure time in patients with gastroesophageal reflux disease (GERD), according to a study published online Jan. 23 in Neurogastroenterology & Motility.
Ram Dickman, M.D., from the Rabin Medical Center in Petah Tikva, Israel, and colleagues assessed the effect of TESS on GERD symptoms and acid exposure time. The analysis included 26 patients who had increased acid exposure time (percent total time pH <4 above 6 percent) and who were treated for up to three weeks with TESS.
The researchers found the mean numbers of daily heartburn and regurgitation episodes were 2.55 and 1.40, respectively, which dropped to 0.77 and 0.36, respectively, following TESS. At baseline, mean acid exposure time and DeMeester score were 12.4 and 32.1, respectively, which dropped to 6.0 and 16.2, respectively, following TESS.
“In summary, TESS appears to be safe and effective in reducing esophageal acid exposure and improving heartburn and regurgitation in GERD patients,” the authors write. “A larger prospective, sham-controlled study is currently designed to verify these early results.”
Ultrasound-Guided Hydrodissection Yields Improvements in Carpal Tunnel 
Nearly 1 in 5 Patients Report Exposure to Ophthalmic Treatments Perceived as Bogus 
People With ADHD Experience 50 Percent More GI Symptoms 
Relapse Rare After Appendiceal Adenocarcinoma Resection .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers 
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction 
